Despite its discovery over 50 years ago, the feline leukemia virus (FeLV) continues to challenge our thinking about the nature of the disease and our ability to diagnose the infection. Testing, vaccination, and segregating progressively infected cats remain effective practices to help control the spread of the disease. Results of this new research are helping to inform improvements in medical decisions and long-term patient care.
Please join Winn Feline Foundation at the second half of our 40th Annual Symposium with Dr. Melissa Beall, DVM, PhD, of IDEXX Laboratories, Portland, ME.
Despite its discovery over 50 years ago, the feline leukemia virus (FeLV) continues to challenge our thinking about the nature of the disease and our ability to diagnose the infection. Testing, vaccination, and segregating progressively infected cats remain effective practices to help control the spread of the disease. Results of this new research are helping to inform improvements in medical decisions and long-term patient care.